REGN20423

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN20423, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis [Phase 1]

See pricing